IP Verse

Samsung Bioepis Nl B.v. opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Samsung Bioepis Nl B.v.

Patent Number:
EP3167888
Title:
Treatment Of Paroxysmal Nocturnal Hemoglobinuria Patients By An Inhibitor Of Complement
Applicant:
ALEXION PHARMACEUTICALS, INC.
Opposition Date:
May 2, 2024
Patent Number:
EP3883606
Title:
Safe And Effective Method Of Treating Ulcerative Colitis With Anti-Il12/Il23 Antibody
Applicant:
JANSSEN BIOTECH, INC.
Opposition Date:
Feb 5, 2024
Patent Number:
EP3403646
Title:
Liquid Pharmaceutical Composition
Applicant:
FRESENIUS KABI DEUTSCHLAND GMBH
Opposition Date:
Oct 5, 2022
Patent Number:
EP3145488
Title:
Liquid Pharmaceutical Composition
Applicant:
ARES TRADING S.A.
Opposition Date:
Apr 22, 2021
Patent Number:
EP3212667
Title:
Pharmaceutical Anti-Tnf-Alpha Antibody Formulation
Applicant:
RICHTER GEDEON NYRT.
Opposition Date:
Dec 12, 2019

Competitors of Samsung Bioepis Nl B.v.

FRESENIUS KABI DEUTSCHLAND GMBH

ALEXION PHARMACEUTICALS, INC.

ARES TRADING S.A.

Want to track Samsung Bioepis Nl B.v.?

Feel free to send us a message here and we will get back to you